Cedar Knolls, NJ (PRWEB) August 26, 2006 -–
Xybion Medical Systems Corporation (Xybion), a developer and supplier of comprehensive preclinical data management systems, including its PATH/TOX SYSTEM™ Next Generation, announced today that Orion Corporation (Orion) has licensed PATH/TOX SYSTEM for the collection, management and reporting of data related to their pharmaceutical research and development activities being conducted at their research sites in Finland.
“We are pleased that Orion has decided to license and deploy the newest version of PATH/TOX SYSTEM to replace the OpenVMS legacy version currently in use at Orion’s facilities,” said David M. Neglia, President of Xybion. “It is rewarding to see that our ongoing investment in development and our commitment to quality products and services is recognized by the market making Xybion the premier preclinical data management solution partner.”
PATH/TOX SYSTEM is a single solution that addresses all aspects of preclinical data acquisition, management and reporting. It is in use in 9 different countries throughout North America, Europe and Asia. Clients have the flexibility to license those components and options needed to support their study protocols and processes providing a client-centric custom solution. Xybion’s products are industry leaders and are used by the world’s largest and most prestigious pharmaceutical, chemical and contract research companies to assess compound safety while reducing the time to market.
# # #